Lauren R. Blankenship

Also affiliated with Drug Discovery Laboratory (Norway), Texas A&M University

MedicineComputer ScienceChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases”.

Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00628

N/A

1.2DataRank · unranked

37 citations

Balachandra Chenna, Kai S. Yang, Taylor R. Cole, Zachary Goodall, Miriam A. Giardini +19 more

A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**

ChemMedChem(2020)10.1002/cmdc.202000924

N/A

0.736DataRank · unranked

134 citations

R. Xinyu, Yuying Ma, Yugendar R. Alugubelli, Danielle A. Scott, Erol C. Vatansever +17 more

A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.17.524469

N/A

0.241DataRank · unranked

4 citations

Sandeep Atla, Namir Shaabani, Veerabhadra R. Vulupala, Kai S. Yang, Yugendar R. Alugubelli +13 more

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114596

N/A

0DataRank · unranked

55 citations

Zhi Geng, Kai S. Yang, Namir Shaabani, Kaustav Khatua, R. Xinyu +13 more

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114570

N/A

0DataRank · unranked

43 citations

Kai S. Yang, Zhi Geng, Yugendar R. Alugubelli, Namir Shaabani, Erol C. Vatansever +13 more

The Pyrrolysyl-tRNA Synthetase Activity can be Improved by a P188 Mutation that Stabilizes the Full-Length Enzyme

Journal of Molecular Biology(2022)10.1016/j.jmb.2022.167453

N/A

0DataRank · unranked

20 citations

Lauren R. Blankenship, Xinyu Ma, Shiqing Xu, Wenshe Ray Liu, Chia-Chuan Cho

Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease

Current Research in Chemical Biology(2022)10.1016/j.crchbi.2022.100025

N/A

0DataRank · unranked

17 citations

Syuan‐Ting Kuo, Lauren R. Blankenship, Zhi Geng, Shuhua G. Li, David H. Russell +4 more

A Novel Y-Shaped, S-O-N-O-S-Bridged Crosslink between Three Residues C22, C44, and K61 Is a Redox Switch of the SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.29.490044

N/A

0DataRank · unranked

3 citations

Syuan‐Ting Kuo, Lauren R. Blankenship, Yan Sheng, Banumathi Sankaran, Pingwei Li +6 more

A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00221

N/A

0DataRank · unranked

25 citations

Sandeep Atla, Namir Shaabani, Veerabhadra R. Vulupala, Kai S. Yang, Yugendar R. Alugubelli +13 more

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.29.560163

N/A

0DataRank · unranked

9 citations

Jing Xiao, Kaustav Khatua, Sathish Kumar, Yuying Ma, R. Xinyu +8 more

An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.11.536467

N/A

0DataRank · unranked

3 citations

Yugendar R. Alugubelli, Kai S. Yang, Veerabhadra R. Vulupala, Lauren R. Blankenship, Demonta Coleman +14 more

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.3c02416

N/A

0DataRank · unranked

75 citations

Jing Xiao, Kaustav Khatua, Sathish Kumar, Long Sun, Yuying Ma +10 more

SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme

ACS Medicinal Chemistry Letters(2024)10.1021/acsmedchemlett.4c00146

N/A

0DataRank · unranked

12 citations

Kai S. Yang, Veerabhadra R. Vulupala, Yugendar R. Alugubelli, Kaustav Khatua, Demonta Coleman +8 more

Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors

Antiviral Research(2024)10.1016/j.antiviral.2024.105874

N/A

0DataRank · unranked

11 citations

Yugendar R. Alugubelli, Kai S. Yang, Veerabhadra R. Vulupala, Lauren R. Blankenship, Demonta Coleman +15 more

A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.28.223784

N/A

0DataRank · unranked

10 citations

R. Xinyu, Yuying Ma, Yugendar R. Alugubelli, Danielle A. Scott, Erol C. Vatansever +17 more

The P3 O - Tert -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.18.473326

N/A

0DataRank · unranked

3 citations

Kai S. Yang, Zhi Geng, Yugendar R. Alugubelli, Namir Shaabani, Erol C. Vatansever +12 more